Age-Related Fertility Factors: What You Need To Know
Written by Dr. Archana Agarwal — Fertility Specialist in Bangalore, Founder & Medical Director
Age is the most consistently documented factor in female fertility — but what that actually means biologically, and what it tells you about your own situation, tends to get lost somewhere between broad population statistics and the kind of reassurance that feels kind but doesn't actually help you plan.
Here is what the evidence says, plainly.
Why Fertility Declines with Age
Women are born with a fixed number of eggs — somewhere between one and two million oocytes at birth, falling to around 300,000–400,000 by puberty. From that point, eggs are lost continuously through a process called atresia, regardless of whether ovulation is occurring or not.
The pill doesn't pause this loss. Neither does pregnancy, or breastfeeding. They suppress ovulation temporarily — but the underlying follicle attrition continues at its own pace, indifferent to what is happening hormonally at the surface.
According to a StatPearls review on age-related fertility decline, this attrition accelerates after the early 30s. And it is not only quantity that declines — quality falls alongside it. As eggs age, the risk of chromosomal abnormalities rises, particularly aneuploidy: an incorrect number of chromosomes in the egg. This is why miscarriage risk increases with age even in women who conceive successfully — many of those losses are the result of chromosomally abnormal embryos that cannot develop to term.
The Key Tests: AMH and Antral Follicle Count
What AMH measures — anti-Müllerian hormone, produced by the small follicles in the ovaries — is the closest thing currently available to a direct read of remaining ovarian reserve without surgery. AMH levels peak in the mid-20s and begin declining from around age 25 onward, making it a useful marker even for women who are still some years from planning a family.
A low AMH for your age group suggests a reduced egg reserve and a potentially shorter window — for natural conception and for assisted reproduction alike.
Antral follicle count, assessed by transvaginal ultrasound on days two or three of your cycle, counts the small visible follicles and cross-validates what the AMH is showing. Neither test predicts how quickly you will conceive in any given cycle. What they give you, together, is a meaningful picture of your ovarian reserve — and a far more useful basis for planning than your age alone.
What Changes, and When
In the early 30s, fertility is still generally good — but it is declining. Per-cycle conception chances drop from roughly twenty-five percent at 25 to around twenty percent by 30, then fall more steeply after that.
By 35, the ACOG recommends evaluation after six months of trying rather than the standard twelve — because the window in which intervention makes a meaningful difference is narrowing, and waiting a full year before investigating costs time that, at that age, carries real consequences.
By 40, per-cycle natural conception chances sit at roughly five percent. By 42 to 43, the cumulative impact of reduced egg quantity and quality makes conception significantly harder even with assisted reproduction.
These are population-level numbers — and individual variation is real, and significant. Some women at 38 carry AMH levels typical of someone a decade younger. Others at 32 have already depleted their reserves considerably more than their age would suggest. The tests exist precisely because age, on its own, is an imprecise predictor for any individual sitting across a desk from a clinician.
What a Result Means — and What It Doesn't
A low AMH is not a sentence. It tells you something important about the likely number of eggs that can be retrieved in a stimulated cycle, and it indicates a potentially shorter natural fertility window. What it does not tell you is whether you can conceive — because egg quality, which AMH does not directly measure, remains the more important variable for any individual embryo reaching term.
Similarly, a reassuringly normal AMH does not mean the fertility conversation can be deferred indefinitely. Reserve and quality decline together, at different rates and in different women, and a single test gives a snapshot — not a forecast.
What both results do is give you real information on which to base a real plan. That is what they are for.
Consult Dr. Archana Agarwal for an Ovarian Reserve Assessment
Age statistics are population data. They describe what happens on average, across large groups. What they cannot tell you is where you specifically sit within that distribution — and that is the question that actually shapes your options.
Dr. Archana Agarwal offers individualised fertility evaluations in Bangalore that include AMH testing, antral follicle count, and a full review of your reproductive history — so that whatever decisions you are facing, you are making them with accurate information rather than borrowed averages. If you have questions about your fertility timeline, a consultation is the clearest place to start.
This article is for general information only and is not a substitute for individualised medical advice. Ovarian reserve testing should be interpreted with a specialist in the context of your full history and reproductive goals
